Cargando…
HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing
BACKGROUND: The Department of Health and Human Services HIV-1 Treatment Guidelines recommend drug resistance testing in HIV-1 RNA to guide the selection of antiretroviral therapy in patients with viremia. However, resistance-associated mutations (RAMs) in HIV-1 RNA may reflect only the patient’s cur...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096913/ https://www.ncbi.nlm.nih.gov/pubmed/37065991 http://dx.doi.org/10.1093/ofid/ofad146 |
_version_ | 1785024453071077376 |
---|---|
author | Curanovic, Dusica Martens, Sharon K Rodriguez, Milka A Hammill, Hunter A Petropoulos, Christos J Walworth, Charles M |
author_facet | Curanovic, Dusica Martens, Sharon K Rodriguez, Milka A Hammill, Hunter A Petropoulos, Christos J Walworth, Charles M |
author_sort | Curanovic, Dusica |
collection | PubMed |
description | BACKGROUND: The Department of Health and Human Services HIV-1 Treatment Guidelines recommend drug resistance testing in HIV-1 RNA to guide the selection of antiretroviral therapy in patients with viremia. However, resistance-associated mutations (RAMs) in HIV-1 RNA may reflect only the patient’s current regimen and can be lost during prolonged absence of therapy. We determined if HIV-1 DNA testing can provide drug resistance information beyond that identified in contemporaneous plasma virus. METHODS: This was a retrospective database review of results obtained for patients with viremia for whom commercial HIV-1 RNA and HIV-1 DNA drug resistance testing was ordered on the same day. Resistance-associated mutations and drug susceptibility calls were compared between paired tests, and the effect of HIV-1 viral load (VL) on test concordance was assessed using Spearmen’s rho correlation. RESULTS: Among 124 paired tests, more RAMs were identified in HIV-1 DNA in 63 (50.8%) cases, and in HIV-1 RNA in 11 (8.87%) cases. HIV-1 DNA testing captured all contemporaneous plasma virus RAMs in 101/117 (86.3%) cases and identified additional RAMs in 63/117 (53.8%) cases. There was a significant positive correlation between the viral load at the time of resistance testing and the percentage of plasma virus RAMs detected in HIV-1 DNA (r(s) = 0.317; P < .001). In 67 test pairs demonstrating pan-sensitive plasma virus, resistance in HIV-1 DNA was seen in 13 (19.4%) cases. CONCLUSIONS: HIV-1 DNA testing identified more resistance than HIV-1 RNA testing in most patients with viremia and may be informative in patients whose plasma virus reverts to wild-type following therapy discontinuation. |
format | Online Article Text |
id | pubmed-10096913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100969132023-04-13 HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing Curanovic, Dusica Martens, Sharon K Rodriguez, Milka A Hammill, Hunter A Petropoulos, Christos J Walworth, Charles M Open Forum Infect Dis Major Article BACKGROUND: The Department of Health and Human Services HIV-1 Treatment Guidelines recommend drug resistance testing in HIV-1 RNA to guide the selection of antiretroviral therapy in patients with viremia. However, resistance-associated mutations (RAMs) in HIV-1 RNA may reflect only the patient’s current regimen and can be lost during prolonged absence of therapy. We determined if HIV-1 DNA testing can provide drug resistance information beyond that identified in contemporaneous plasma virus. METHODS: This was a retrospective database review of results obtained for patients with viremia for whom commercial HIV-1 RNA and HIV-1 DNA drug resistance testing was ordered on the same day. Resistance-associated mutations and drug susceptibility calls were compared between paired tests, and the effect of HIV-1 viral load (VL) on test concordance was assessed using Spearmen’s rho correlation. RESULTS: Among 124 paired tests, more RAMs were identified in HIV-1 DNA in 63 (50.8%) cases, and in HIV-1 RNA in 11 (8.87%) cases. HIV-1 DNA testing captured all contemporaneous plasma virus RAMs in 101/117 (86.3%) cases and identified additional RAMs in 63/117 (53.8%) cases. There was a significant positive correlation between the viral load at the time of resistance testing and the percentage of plasma virus RAMs detected in HIV-1 DNA (r(s) = 0.317; P < .001). In 67 test pairs demonstrating pan-sensitive plasma virus, resistance in HIV-1 DNA was seen in 13 (19.4%) cases. CONCLUSIONS: HIV-1 DNA testing identified more resistance than HIV-1 RNA testing in most patients with viremia and may be informative in patients whose plasma virus reverts to wild-type following therapy discontinuation. Oxford University Press 2023-03-22 /pmc/articles/PMC10096913/ /pubmed/37065991 http://dx.doi.org/10.1093/ofid/ofad146 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Curanovic, Dusica Martens, Sharon K Rodriguez, Milka A Hammill, Hunter A Petropoulos, Christos J Walworth, Charles M HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title | HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title_full | HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title_fullStr | HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title_full_unstemmed | HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title_short | HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing |
title_sort | hiv-1 dna testing in viremic patients identifies more drug resistance than hiv-1 rna testing |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096913/ https://www.ncbi.nlm.nih.gov/pubmed/37065991 http://dx.doi.org/10.1093/ofid/ofad146 |
work_keys_str_mv | AT curanovicdusica hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting AT martenssharonk hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting AT rodriguezmilkaa hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting AT hammillhuntera hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting AT petropouloschristosj hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting AT walworthcharlesm hiv1dnatestinginviremicpatientsidentifiesmoredrugresistancethanhiv1rnatesting |